Iterum Therapeutics plcIterum Therapeutics plcIterum Therapeutics plc

Iterum Therapeutics plc

No trades

SEC filings and other documents


Explore the latest company documents and SEC filings from the company, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.
Event/report
Event date
Documents and forms
2025
Q3 2025
Nov 14, 2025
Earnings release8-K
Quarterly report10-Q
Transcript
Q2 2025
Aug 5, 2025
Earnings release8-K
Quarterly report10-Q
Transcript
Status Update
Jun 11, 2025
Press release
Transcript
Q1 2025
May 13, 2025
Earnings release8-K
Quarterly report10-Q
Transcript
2024
Q4 2024
Feb 7, 2025
Annual report10-K
Earnings release8-K
Transcript
Q3 2024
Nov 14, 2024
Earnings release8-K
Quarterly report10-Q
Transcript
FDA Announcement
Oct 28, 2024
Press release
Transcript
Maxim Group’s 2024 Healthcare Virtual Summit
Oct 16, 2024
Transcript
Q2 2024
Aug 14, 2024
Earnings release8-K
Quarterly report10-Q
Transcript
Investor Presentation
Jul 2, 2024
Slides
Q1 2024
May 13, 2024
Earnings release8-K
Quarterly report10-Q
Transcript
Study Result
Jan 30, 2024
Press release
Slides
2023
Q4 2023
Mar 28, 2024
Annual report10-K
Earnings release8-K
Transcript
Q3 2023
Nov 14, 2023
Earnings release8-K
Quarterly report10-Q
Q2 2023
Aug 11, 2023
Earnings release8-K
Quarterly report10-Q
Q1 2023
May 12, 2023
Earnings release8-K
Quarterly report10-Q
2022
Q4 2022
Mar 16, 2023
Annual report10-K
Earnings release8-K
Q3 2022
Nov 10, 2022
Earnings release8-K
Quarterly report10-Q
Q2 2022
Aug 12, 2022
Earnings release8-K
Quarterly report10-Q
Q1 2022
May 13, 2022
Earnings release8-K
Quarterly report10-Q
2021
Q4 2021
Mar 28, 2022
Annual report10-K
Earnings release8-K
Q3 2021
Nov 12, 2021
Earnings release8-K
Quarterly report10-Q
Q2 2021
Aug 13, 2021
Earnings release8-K
Quarterly report10-Q
Q1 2021
May 14, 2021
Earnings release8-K
Quarterly report10-Q
2020
Q4 2020
Mar 12, 2021
Annual report10-K
2019
Q4 2019
Mar 12, 2020
Annual report10-K
2018
Q4 2018
Mar 25, 2019
Annual report10-K